Vandria
PrivateLast Round
Grant
Aug 22, 2024
Total Funding Raised
$71.3M
Company Overview
Vandria is a biotechnology company that develops first-in-class small molecule mitophagy inducers to rejuvenate cells and treat age-related and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vandria Comparables
Compare Vandria with similar companies based on industry and business-model similarity.
Vandria Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 22, 2024 | ||||
| Series A | Aug 21, 2024 | ||||
| Grant | Feb 8, 2024 | ||||
| Series A | Dec 14, 2023 | ||||
| Seed | Sep 1, 2021 |
Vandria Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Series A |
| +ND Capital | Series A |
| Hevolution Foundation | Series A |
| Eurostars SME programme | Grant |
| Innosuisse | Grant |
| ND Capital | Series A, Seed |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 14, 2023
$31M round led by ND Capital.
Vandria Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vandria's valuation, stock price, and market status.